Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial (Q46778815)
Jump to navigation
Jump to search
scientific article published in November 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial |
scientific article published in November 2005 |
Statements
1 reference
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial (English)
1 reference
Annelies Boonen
1 reference
Björn Svensson
1 reference
Kristina Albertsson
1 reference
Catharina Keller
1 reference
Ingiäld Hafström
1 reference
1 November 2005
1 reference
52
1 reference
11
1 reference
3360-3370
1 reference
1 reference
Identifiers
1 reference
1 reference